Argenx Upgraded at Wolfe on Myasthenia Gravis Dominance

Seeking AlphaNov 13 00:03

Express News | Immunovant Inc : Citigroup Cuts Target Price to $58 From $60

BreakingsNov 11 19:34

Immunovant's Strategic Advances in Autoimmune Therapies

TipRanksNov 9 12:22

H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $51

Futu NewsNov 9 01:32 · Ratings

Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus

Zacks Nov 8 23:05

A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $48 to $58

Futu NewsNov 8 21:00 · Ratings